Compare NPCE & OPTU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NPCE | OPTU |
|---|---|---|
| Founded | 1997 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Cable & Other Pay Television Services |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 490.2M | 411.9M |
| IPO Year | 2021 | 2017 |
| Metric | NPCE | OPTU |
|---|---|---|
| Price | $12.42 | $0.98 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 10 | 13 |
| Target Price | ★ $20.00 | $1.05 |
| AVG Volume (30 Days) | 113.5K | ★ 1.6M |
| Earning Date | 11-03-2026 | 11-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 29.03 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $99,986,000.00 | ★ $8,590,467,000.00 |
| Revenue This Year | $0.32 | N/A |
| Revenue Next Year | $22.05 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 25.13 | N/A |
| 52 Week Low | $9.22 | $0.58 |
| 52 Week High | $19.60 | $2.14 |
| Indicator | NPCE | OPTU |
|---|---|---|
| Relative Strength Index (RSI) | 29.52 | 46.50 |
| Support Level | N/A | $0.91 |
| Resistance Level | $15.26 | $1.13 |
| Average True Range (ATR) | 0.56 | 0.08 |
| MACD | -0.18 | -0.01 |
| Stochastic Oscillator | 3.77 | 25.77 |
NeuroPace Inc is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of seizures. The company offers the RNS System, a brain-responsive neuromodulation system that continuously monitors and analyzes the brain's electrical activity and delivers personalized, real-time electrical pulses at the seizure source to prevent seizures. The RNS System includes the RNS neurostimulator, cortical strip leads, depth leads, a Patient Remote Monitor, and other implantable and non-implantable accessories used during implant procedures. The company also provides the Physician Tablet, Patient Data Management System, and the nSight Platform to facilitate ongoing patient monitoring and support clinicians in managing patient care.
Optimum's assets were brought together when Altice Europe acquired US cable companies Suddenlink in 2015 and Cablevision in 2016. The Suddenlink business, which management calls the "West," provides television, internet access, and phone services to roughly 4.5 million US homes and businesses located primarily in smaller markets, with major clusters in Texas, West Virginia, Idaho, Arizona, and Louisiana. The Cablevision portion, dubbed the "East," provides comparable services to about 5.5 million homes and businesses in the New York City metro area. Both regions now operate under the Optimum brand name. Altice Europe spun off Optimum, which includes both the Suddenlink and Cablevision operations, to shareholders in 2018.